Outperform, C$210.00 price target
We expect Kinaxis to report a solid quarter, with revenue in line with consensus and continued SaaS and ARR growth momentum. As a result of Kinaxis’ high visibility and strong pipeline, we believe Kinaxis may increase FY23 guidance. Moreover, Kinaxis may report Q1 adj. EBITDA above consensus, which appears overly conservative. Maintain Outperform.
Kinaxis is reporting Q1/FY23 on May 3. Kinaxis is reporting Q1/FY23 results on May 3, after market close. The conference call is scheduled for May 4 at 8:30 a.m. ET. Webcast available here.
Even though headlines are likely to be lacklustre, Q1 is expected to be a healthy quarter, with SaaS up 29% Y/Y CC. Due to the timing of term license renewals, we forecast Q1 revenue up only 3% Y/Y to $101MM, which matches consensus. As a result of the decline in high margin term license (down 72% Y/Y), we model adj. EBITDA to fall 34% Y/Y to $22MM (consensus at $17MM) and adj. EPS down 30% Y/Y to $0.46 (consensus at $0.36). Despite these headlines, we expect the quarter to be fundamentally solid, with SaaS revenue up likely 26% Y/Y (29% CC), an improvement from 22% (28% CC) in FY22.
Based on movements in FX, FX is likely a diminishing headwind to Kinaxis’ revenue. We estimate FX could be a $2.5MM headwind (250 bps Y/Y) to Q1 revenue, slightly below the $2.9MM in our model and down materially from $5.0MM Q4.